1. Home
  2. MRUS vs COMP Comparison

MRUS vs COMP Comparison

Compare MRUS & COMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • COMP
  • Stock Information
  • Founded
  • MRUS 2003
  • COMP 2012
  • Country
  • MRUS Netherlands
  • COMP United States
  • Employees
  • MRUS 260
  • COMP N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • COMP EDP Services
  • Sector
  • MRUS Health Care
  • COMP Technology
  • Exchange
  • MRUS Nasdaq
  • COMP Nasdaq
  • Market Cap
  • MRUS 4.1B
  • COMP 3.9B
  • IPO Year
  • MRUS 2016
  • COMP 2021
  • Fundamental
  • Price
  • MRUS $53.11
  • COMP $6.12
  • Analyst Decision
  • MRUS Strong Buy
  • COMP Buy
  • Analyst Count
  • MRUS 12
  • COMP 6
  • Target Price
  • MRUS $87.92
  • COMP $10.17
  • AVG Volume (30 Days)
  • MRUS 2.0M
  • COMP 6.6M
  • Earning Date
  • MRUS 07-31-2025
  • COMP 07-30-2025
  • Dividend Yield
  • MRUS N/A
  • COMP N/A
  • EPS Growth
  • MRUS N/A
  • COMP N/A
  • EPS
  • MRUS N/A
  • COMP N/A
  • Revenue
  • MRUS $54,732,000.00
  • COMP $5,931,200,000.00
  • Revenue This Year
  • MRUS $75.57
  • COMP $25.51
  • Revenue Next Year
  • MRUS $31.84
  • COMP $13.79
  • P/E Ratio
  • MRUS N/A
  • COMP N/A
  • Revenue Growth
  • MRUS 42.77
  • COMP 19.05
  • 52 Week Low
  • MRUS $33.19
  • COMP $3.34
  • 52 Week High
  • MRUS $62.98
  • COMP $10.25
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 53.18
  • COMP 44.56
  • Support Level
  • MRUS $52.41
  • COMP $5.87
  • Resistance Level
  • MRUS $54.59
  • COMP $6.45
  • Average True Range (ATR)
  • MRUS 2.15
  • COMP 0.25
  • MACD
  • MRUS -0.77
  • COMP 0.04
  • Stochastic Oscillator
  • MRUS 7.62
  • COMP 48.02

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

Share on Social Networks: